Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7651 AL 7665

P-glycoprotein and Alzheimer's Disease: Threats and Opportunities

Asante JJ Jr, Barger SW.

ASN Neuro. 2025;17(1):2495632. doi: 10.1080/17590914.2025.2495632. Epub 2025 Apr 23.

Iridoid glycosides in kidney-tonifying Chinese medicinal herbs: Mechanisms and implications for Alzheimer's disease therapy

Qu Y, Ding M, Zhang M, Zheng L, Hu B, An H.

J Ethnopharmacol. 2025 May 28;348:119870. doi: 10.1016/j.jep.2025.119870. Epub 2025 Apr 25.

Ferroptosis in Alzheimer's Disease: The Regulatory Role of Glial Cells

Xu J, Shen R, Qian M, Zhou Z, Xie B, Jiang Y, Yu Y, Dong W.

J Integr Neurosci. 2025 Apr 24;24(4):25845. doi: 10.31083/JIN25845.

Role of mGluR7 in Alzheimer's disease: pathophysiological insights and therapeutic approaches

Hunjan G, Aran KR.

Inflammopharmacology. 2025 Jun;33(6):2977-2995. doi: 10.1007/s10787-025-01765-3. Epub 2025 May 3.

Research progress of cell senescence in Alzheimer's disease: mechanisms and therapy

Cai J, Yang L, Xu Y, Wang L, Zhang M, Qiao J, Xu Q, Zhu H, Cai M.

Eur J Pharmacol. 2025 Sep 5;1002:177697. doi: 10.1016/j.ejphar.2025.177697. Epub 2025 May 2.

Recent Advances in Drug Development for Alzheimer's Disease: A Comprehensive Review

Xing H, Yue S, Qin R, Du X, Wu Y, Zhangsun D, Luo S.

Int J Mol Sci. 2025 Apr 21;26(8):3905. doi: 10.3390/ijms26083905.

NGF-based cholinergic therapies in Alzheimer disease

Mitra S, Gera R, Eriksdotter M.

Handb Clin Neurol. 2025;211:123-135. doi: 10.1016/B978-0-443-19088-9.00007-X.

Evaluation of Illumina and Oxford Nanopore Sequencing for the Study of DNA Methylation in Alzheimer's Disease and Frontotemporal Dementia

Pagano L, Lagrotteria D, Facconi A, Saraceno C, Longobardi A, Bellini S, Ingannato A, Bagnoli S, Ducci T, Mingrino A, Laganà V, Paparazzo E, Borroni B, Maletta R, Nacmias B, Montesanto A, Ghidoni R.

Int J Mol Sci. 2025 Apr 28;26(9):4198. doi: 10.3390/ijms26094198.

[Expert consensus on disease-modifying therapy for Alzheimer's disease (2025 edition)]

Neurologist Branch, Chinese Medical Doctor Association; Expert Group for Expert Consensus on Disease-Modifying Therapy for Alzheimer′s Disease.

Zhonghua Yi Xue Za Zhi. 2025 May 20;105(19):1492-1502. doi: 10.3760/cma.j.cn112137-20250304-00512. Epub 2025 Mar 18.

Decoding the role of glucocorticoid-regulated kinase 1 in Alzheimer's disease: a promising path toward novel therapeutic strategies

Mittal Y, Kumar P, Joshi K, Aran KR.

Inflammopharmacology. 2025 Jun;33(6):2997-3013. doi: 10.1007/s10787-025-01777-z. Epub 2025 May 15.

Anti-Amyloid Agents: A Self-Fulfilling prophecy

Giannakis A, Konitsiotis S.

J Clin Neurosci. 2025 Jul;137:111338. doi: 10.1016/j.jocn.2025.111338. Epub 2025 May 19.

Glycation in Alzheimer's Disease and Type 2 Diabetes: The Prospect of Dual Drug Approaches for Therapeutic Interventions

Ayoub S, Arabi M, Al-Najjar Y, Laswi I, Outeiro TF, Chaari A.

Mol Neurobiol. 2025 Nov;62(11):14859-14882. doi: 10.1007/s12035-025-05051-9. Epub 2025 May 22.

A 2025 update on treatment strategies for the Alzheimer's disease spectrum

Wu CK, Fuh JL.

J Chin Med Assoc. 2025 Jul 1;88(7):495-502. doi: 10.1097/JCMA.0000000000001252. Epub 2025 May 30.

Therapeutic Advances in Alzheimer’s Disease: Integrating Natural, Semi-Synthetic, and Synthetic Drug Strategies

Chauhan BS, Singh YP, Poeggeler B, Singh SK.

Curr Alzheimer Res. 2025;22(9):661-677. doi: 10.2174/0115672050366727250513061730.

Impairment of Tricarboxylic Acid Cycle (TCA) Cycle in Alzheimer's Disease: Mechanisms, Implications, and Potential Therapies

Mohan GS, Kumar R.

Aging Dis. 2025 May 29;16(5):2553-2574. doi: 10.14336/AD.2025.0472.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias